Depression In Boys And Adolescent Males
Depression in Boys and Adolescent Males
Only in the past two decades has depression in children been taken very seriously. Research has revealed that depression is occurring earlier in life today than in past decades. In addition, research has shown that early onset depression often persists, recurs, and continues into adulthood, and that depression in youth may also predict more severe illness in adult life. An NIMH sponsored study of 9 to 17 year olds estimates that the prevalence of any depressive disorder is more than 6 percent in a six month period, with 4.9 percent having major depression. Before puberty, boys and girls are equally likely to develop depressive disorders. After age 14, however, females are twice as likely as males to have major depression or dysthymia. The risk of developing bipolar disorder remains approximately equal for males and females throughout adolescence and adulthood.
The depressed younger child may say he is sick, refuse to go to school, cling to a parent, or worry that the parent may die. The depressed older child may sulk, get into trouble at school, be negative and grouchy, and feel misunderstood. Signs of depressive disorders in young people are often viewed as normal mood swings typical of a particular developmental stage. In addition, health care professionals may be reluctant to prematurely label a young person with a mental illness diagnosis. However, early diagnosis and treatment of depressive disorders are critical to healthy emotional, social, and behavioral development. Depression in young people frequently co occurs with other mental disorders, most commonly anxiety, disruptive behavior, or substance abuse disorders, as well as with other serious illnesses such as diabetes.
Among both children and adolescents, depressive disorders confer an increased risk for illness and interpersonal and psychosocial difficulties that persist long after the depressive episode is resolved; in adolescents, there is also an increased risk for substance abuse and suicidal behavior. Unfortunately, these disorders often go unrecognized by families and physicians alike.
Although the scientific literature on treatment of children and adolescents with depression is far less extensive than that for adults, a number of recent studies have confirmed the short term efficacy and safety of treatments for depression in youth. An NIMH funded clinical trial of 439 adolescents with major depression found that a combination of medication and psychotherapy is the most effective treatment. Additional research is needed on how best to incorporate these treatments into primary care practice.
Bipolar disorder, although rare in young children, can appear in both children and adolescents. The unusual shifts in mood, energy, and functioning that are characteristic of bipolar disorder may begin with manic, depressive, or mixed manic and depressive symptoms. It is more likely to affect the children of parents who have the illness. Twenty to 40 percent of adolescents with major depression go on to reveal bipolar disorder within five years after the onset of depression.
Depression in children and adolescents is associated with an increased risk of suicidal behaviors. This risk may rise, particularly among adolescent males, if the depression is accompanied by conduct disorder and alcohol or other substance abuse. In 2002, suicide was the third leading cause of death among young males, age 15 to 24. NIMH supported researchers found that among adolescents who develop major depressive disorder, as many as 7 percent may die by suicide in the young adult years. Therefore, it is important for doctors and parents to take seriously any remarks about suicide.
NIMH researchers are developing and testing various interventions to prevent suicide in children and adolescents. Early diagnosis and treatment, accurate evaluation of suicidal thinking, and limitations on young peoples access to lethal agentsincluding firearms and medicationsmay hold the greatest suicide prevention value.
Persons with cancer, their families and friends, and even their physicians and oncologists (physicians specializing in cancer treatment) may misinterpret depression's warning signs, mistaking them for inevitable accompaniments to cancer.
It is important to keep taking medication until it has a chance to work, though side effects may appear before antidepressant activity does.
Insomnia and Depression are Linked
Insomnia and Depression are Linked Aug 27th, 2007 by cherished79 Research has shown that insomnia is actually a risk factor for depression. Studies indicate that people with insomnia who got help for their sleep problems had a lower incidence of major depression a year later than those
Prism Casino Affiliate Programs - #1 Online Casino Affiliate Program
Prism Casino Affiliate Programs - #1 Online Casino Affiliate Program Posted in depression by admin @ Aug 27, 2007 - Comments (0) Prism Affiliate - The Ultimate Casino Affiliate Program
Earn easy money through the IrishAbroad.com affiliate program.
Earn easy money through the IrishAbroad.com affiliate program. Posted in depression by admin @ Aug 27, 2007 - Comments (0) Earn easy money through the IrishAbroad.com affiliate program. Anyone with a website, big or small, can become an Affiliate.
Other Depression Article Snippets:
How To Help Yourself If You Are Depressed
"Today in Germany, Hypericum is used in the treatment of depression more than any other antidepressant, however, the scientific studies that have been conducted on its use have been short-term and have used several different doses."
Herbal Therapy Against Depression
"Although depression itself can lower libido and impair sexual performance, SSRIs and some other antidepressants can provoke sexual dysfunction."
Causes Of Depression
"Once the person is feeling better, it is important to continue the medication for at least four to nine months to prevent a relapse into depression."
Depression And Suicide
"There are several types of antidepressant medications used to treat depressive disorders like newer medications chiefly the selective serotonin reuptake inhibitors (SSRIs) the tricyclics, and the monoamine oxidase inhibitors (MAOIs)."